Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression (Q85736057)
Jump to navigation
Jump to search
scientific article published on 01 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression |
scientific article published on 01 January 2013 |
Statements
Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression (English)
Pengcheng Shi
Jie Zha
Xutao Guo
Feili Chen
Zhiping Fan
Fen Huang
Fanyi Meng
Xiaoli Liu
Ru Feng
1 January 2013